China National Medicines Corp Ltd (600511) — Capital Reinvestment Ratio
China National Medicines Corp Ltd (600511) has a Capital Reinvestment Ratio of 0.03x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥382.74 Million) in capital expenditures (CN¥13.23 Million). Check 600511 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
China National Medicines Corp Ltd Capital Reinvestment Ratio (2002–2024)
This chart tracks China National Medicines Corp Ltd's Capital Reinvestment Ratio across 22 annual periods. For the full cash flow conversion analysis, see China National Medicines Corp Ltd (600511) cash conversion ratio.
Annual Capital Reinvestment Ratio for China National Medicines Corp Ltd (2002–2024)
Year-by-year Capital Reinvestment Ratio for China National Medicines Corp Ltd from 2002 to 2024. See 600511 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.08x | CN¥1.66 Billion | CN¥130.77 Million | ▲ +48.1% |
| 2023 | 0.05x | CN¥2.73 Billion | CN¥145.12 Million | ▼ -1.8% |
| 2022 | 0.05x | CN¥2.40 Billion | CN¥129.78 Million | ▲ +11.6% |
| 2021 | 0.05x | CN¥1.96 Billion | CN¥95.07 Million | ▼ -8.5% |
| 2020 | 0.05x | CN¥1.30 Billion | CN¥69.05 Million | ▲ +9.9% |
| 2019 | 0.05x | CN¥1.78 Billion | CN¥85.72 Million | ▼ -64.2% |
| 2018 | 0.13x | CN¥981.65 Million | CN¥132.46 Million | ▲ +97.9% |
| 2017 | 0.07x | CN¥1.07 Billion | CN¥73.25 Million | ▲ +1.1% |
| 2016 | 0.07x | CN¥591.25 Million | CN¥39.88 Million | ▼ -56.6% |
| 2015 | 0.16x | CN¥440.29 Million | CN¥68.47 Million | ▼ -77.0% |
| 2014 | 0.68x | CN¥218.94 Million | CN¥148.22 Million | ▲ +3.3% |
| 2013 | 0.66x | CN¥185.56 Million | CN¥121.66 Million | ▼ -28.2% |
| 2012 | 0.91x | CN¥185.87 Million | CN¥169.65 Million | ▲ +1105.7% |
| 2010 | 0.08x | CN¥318.21 Million | CN¥24.09 Million | ▼ -13.5% |
| 2009 | 0.09x | CN¥255.18 Million | CN¥22.33 Million | ▲ +17.2% |
| 2008 | 0.07x | CN¥217.10 Million | CN¥16.21 Million | ▼ -31.1% |
| 2007 | 0.11x | CN¥79.48 Million | CN¥8.61 Million | ▼ -44.7% |
| 2006 | 0.20x | CN¥121.50 Million | CN¥23.81 Million | ▼ -56.2% |
| 2005 | 0.45x | CN¥92.20 Million | CN¥41.24 Million | ▼ -74.7% |
| 2004 | 1.77x | CN¥49.18 Million | CN¥87.08 Million | ▼ -99.0% |
| 2003 | 172.79x | CN¥526.15K | CN¥90.92 Million | ▲ +18401.7% |
| 2002 | 0.93x | CN¥15.19 Million | CN¥14.19 Million | — |